- Home
- SWIN vs ELEV Comparison
SWIN vs ELEV Comparison
Compare SWIN & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- ELEV
- Stock Information
- Founded
- SWIN 2017
- ELEV 2019
- Country
- SWIN Hong Kong
- ELEV United States
- Employees
- SWIN N/A
- ELEV N/A
- Industry
- SWIN
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- SWIN
- ELEV Health Care
- Exchange
- SWIN Nasdaq
- ELEV Nasdaq
- Market Cap
- SWIN 41.7M
- ELEV 34.0M
- IPO Year
- SWIN 2023
- ELEV 2021
- Fundamental
- Price
- SWIN $2.51
- ELEV $0.60
- Analyst Decision
- SWIN
- ELEV Strong Buy
- Analyst Count
- SWIN 0
- ELEV 5
- Target Price
- SWIN N/A
- ELEV $7.80
- AVG Volume (30 Days)
- SWIN 105.8K
- ELEV 686.4K
- Earning Date
- SWIN 11-29-2024
- ELEV 11-06-2024
- Dividend Yield
- SWIN N/A
- ELEV N/A
- EPS Growth
- SWIN N/A
- ELEV N/A
- EPS
- SWIN N/A
- ELEV N/A
- Revenue
- SWIN $3,437,000.00
- ELEV N/A
- Revenue This Year
- SWIN N/A
- ELEV N/A
- Revenue Next Year
- SWIN N/A
- ELEV N/A
- P/E Ratio
- SWIN N/A
- ELEV N/A
- Revenue Growth
- SWIN N/A
- ELEV N/A
- 52 Week Low
- SWIN $2.01
- ELEV $0.44
- 52 Week High
- SWIN $72.55
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- SWIN 46.05
- ELEV 48.04
- Support Level
- SWIN $2.15
- ELEV $0.52
- Resistance Level
- SWIN $2.60
- ELEV $0.70
- Average True Range (ATR)
- SWIN 0.23
- ELEV 0.05
- MACD
- SWIN 0.00
- ELEV -0.00
- Stochastic Oscillator
- SWIN 50.72
- ELEV 28.64
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.